Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities

H El-Gabalawy, LC Guenther… - The Journal of …, 2010 - jrheum.org
Immune-mediated inflammatory diseases (IMID) present a group of common and highly
disabling chronic conditions that share inflammatory pathways. Several incidence and …

Socioeconomic burden of immune-mediated inflammatory diseases—focusing on work productivity and disability

P Jacobs, R Bissonnette, LC Guenther - The Journal of Rheumatology …, 2011 - jrheum.org
Chronic disabling conditions, such as immune-mediated inflammatory diseases (IMID),
adversely affect patients in terms of physical suffering and pain, impaired function, and …

The role of inflammation in the pathophysiology of depression: different treatments and their effects

FE Lotrich, H El-Gabalawy, LC Guenther… - The Journal of …, 2011 - jrheum.org
Compelling evidence suggests that inflammation contributes to the development of depression.
Many depressed individuals have higher levels of proinflammatory mediators, which …

Optimizing treatment with topical tazarotene

LC Guenther - American journal of clinical dermatology, 2003 - Springer
Tazarotene is a receptor-selective retinoid, which is efficacious in the treatment of patients
with psoriasis, acne vulgaris, and photoaging. It normalizes keratinocyte differentiation, …

Acitretin use in dermatology

LC Guenther, R Kunynetz, CW Lynde… - Journal of …, 2017 - journals.sagepub.com
Background: Acitretin has been used for the treatment of severe psoriasis for over 20 years.
Objective: The current project was conceived to optimise patient care by recognising the role …

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study

…, D Thaçi, J Bagel, LC Guenther, C Paul… - Journal of …, 2022 - Taylor & Francis
… LC Guenther has served as a consultant, investigator, and speaker for AbbVie, Amgen,
Bausch Health, Celgene, Eli Lilly, GlaxoSmithKline, Janssen, LEO Pharma, Merck, Novartis, …

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of …

LC Guenther, YP Poulin, DM Pariser - Clinical therapeutics, 2000 - Elsevier
Background: Both tazarotene (a retinoid prodrug) and calcipotriene (a synthetic analog of
vitamin D 3 ) are effective in the treatment of plaque psoriasis, but no reports in the literature …

[HTML][HTML] Simultaneous nail and skin clearance in ixekizumab head-to-head trials for moderate-to-severe psoriasis and psoriatic arthritis

…, R Burge, JF Merola, AB Gottlieb, LC Guenther - Dermatology and …, 2022 - Springer
Introduction The lifetime incidence of nail psoriasis in patients with psoriasis is 80–90%,
with 23–27% of patients having nail psoriasis at any given time. Nail psoriasis is even more …

A review of common pediatric lip lesions: herpes simplex/recurrent herpes labialis, impetigo, mucoceles, and hemangiomas

JM Bentley, B Barankin, LC Guenther - Clinical pediatrics, 2003 - journals.sagepub.com
Lip lesions are a common presentation to the pediatrician's office. These lesions are often
benign in children, without significant functional morbidity. However, owing to the prominent …

Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic

…, J DeKoven, LC Guenther, C Muhn… - SAGE Open …, 2021 - journals.sagepub.com
The severe acute respiratory syndrome coronavirus 2 pandemic has necessitated enhanced
protection against viral transmission among healthcare professionals, particularly relating …